680 filings
Page 15 of 34
6-K
iqhfzr1g0ckoumr 1j5
18 Oct 19
RedHill Biopharma Announces $36 Million Strategic Investment by Cosmo Pharmaceuticals and U.S. Rights to Approved Travelers’ Diarrhea Drug AEMCOLO
6:00am
6-K
gi61ai sfi
16 Oct 19
Current report (foreign)
8:00am
6-K
71wbdmt
11 Oct 19
Current report (foreign)
9:00am
6-K
tgvhpr390ui fjqw3i
30 Sep 19
Current report (foreign)
6:30am
6-K
dkkfg
26 Sep 19
RedHill Biopharma Provides H2/2019 R&D Update
8:00am
6-K
b69 wrljx98e
27 Aug 19
RedHill Biopharma to Present at Upcoming Investor Conferences in September
7:00am
6-K
n5rr6l3mzk x4
21 Aug 19
Current report (foreign)
7:00am
6-K
c6w6da8d
23 Jul 19
Current report (foreign)
8:31am
6-K
oqt 5mor9iydq5z94tn
23 Jul 19
Current report (foreign)
7:27am
6-K
218 adki8cm8
15 Jul 19
Current report (foreign)
7:00am
6-K
kx3s1harsl6ya1q7
3 Jul 19
Current report (foreign)
7:00am
6-K
1bqtp51 3lx3s
24 Jun 19
Current report (foreign)
9:00am
6-K
ybgp7ktbyqddf40
10 Jun 19
RedHill Biopharma Receives Allowance for New U.S. Patent Covering RHB-104 for Crohn’s Disease and RHB-204 for NTM Infections
8:00am
6-K
jmh6f3hwu xwp
28 May 19
RedHill Biopharma Appoints Dr. June Almenoff as Chief Scientific Officer
7:00am
6-K
838j ryff
23 May 19
RedHill Biopharma to Present at 2019 BIO International Convention
8:00am
6-K
etwpc7 sjq7
21 May 19
RedHill Biopharma Expands Commercial Management Team Ahead of Planned Talicia® Launch
7:01am
6-K
6vhsrjwjbmzj
16 May 19
Current report (foreign)
9:01am
6-K
6rujdbkwj2o3 unu9rot
9 May 19
Current report (foreign)
8:01am
6-K
iqjyrc wb36gj
7 May 19
Current report (foreign)
7:01am
6-K
viaddl5kdvq6ruyv ie
7 May 19
RedHill Biopharma Submits New Drug Application for Talicia® for H. pylori Infection
6:06am